Exploring a Chronic and Painful Inflammatory Skin Disease

Iltefat Hamzavi, MD, introduces a discussion on the treatment of hidradenitis suppurativa with an overview of the signs and symptoms of the disease.

An expert on hidradenitis suppurativa discusses the epidemiology of the disease and its profound impact on patients’ lives.

Iltefat Hamzavi, MD, describes the pathophysiology of hidradenitis suppurativa and associated comorbidities that are commonly seen in patients.

A dermatologist provides clinical insights on differential diagnosis strategies when considering hidradenitis suppurativa in patients and the challenges associated with diagnosis.

An expert on hidradenitis suppurativa describes the characteristics for each of the 3 stages in the Hurley staging system and how they inform treatment decisions.

Iltefat Hamzavi, MD, outlines comorbidities associated with hidradenitis suppurativa and discusses best practices for coordinating care between specialists.

Dr Hamzavi discusses how clinicians can address the psychosocial impact of hidradenitis suppurativa on patients and the rate of hospitalization.

Iltefat Hamzavi, MD, discusses the importance of support groups and other helpful resources for families and caregivers of patients with hidradenitis suppurativa and provides closing thoughts for clinical providers.

An expert on hidradenitis suppurativa (HS) provides an overview of the Hurley staging system and discusses unmet needs in the overall treatment landscape.

Vivian Shi, MD, FAAD, provides an overview of current treatment guidelines for hidradenitis suppurativa and discusses ways to improve upon them.

A dermatologist outlines the role for biologic therapies in the hidradenitis suppurativa treatment landscape and discusses the importance of early intervention.

Vivian Shi, MD, FAAD, reviews recent phase 3 data on bimekizumab, a biologic therapy for patients with hidradenitis suppurativa.

An expert on hidradenitis suppurativa gives an overview of the current research landscape, highlighting exciting developments in the treatment space.

A dermatologist provides clinical insights on managing pain in patients with hidradenitis suppurativa.

Dr. Shi provides insights on patients with hidradenitis suppurativa for whom surgical intervention would be an appropriate treatment modality.

Vivian Shi, MD, FAAD, offers clinical insights on best practices for optimizing multidisciplinary care of patients with hidradenitis suppurativa.